Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The activities and participation categories of the ICF Core Sets for multiple sclerosis from the patient perspective.
Unusual Manifestations of Pediatric Neuromyelitis Optica.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System.
Menarche increases relapse risk in pediatric multiple sclerosis.
Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.
Functioning assessment vs. conventional medical assessment: a comparative study on health professionals' clinical decision-making and the fit with patient's own perspective of health.
DNase hypersensitive sites and association with multiple sclerosis.
Possible second motor neuron damage in neuromyelitis optica.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
Therapeutic potential of cannabinoid medicines.
A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
Multiple sclerosis rehabilitation.
Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain.
Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran).
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females.
PEGylated IFNβ-1a in the treatment of multiple sclerosis.
CX3CR1 in multiple sclerosis.
C1-C2 X-Ray assessment of misalignment parameters in patients with Chronic Cerebra-spinal Venous Insufficiency and Multiple Sclerosis versus patients with other pathologies.
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
Pages
« first
‹ previous
…
427
428
429
430
431
432
433
434
435
…
next ›
last »